Child and Adolescent Psychopharmacology News

Edited by Adelaide S. Robb, MD
Children’s National Health System; George Washington University

ISSN: 10850295

As of December 2018, Child and Adolescent Psychopharmacology News will cease publication with Volume 22, Number 6. Please contact news@guilford.com for any further information.

Online Content Features:

Adelaide S. Robb, MD, is a psychopharmacologist with ongoing research studies in major depression, anxiety, bipolar disorder, schizophrenia, autism, and ADHD for medication management. Dr. Robb is Chief of the Division of Psychology and Behavioral Health, at Children’s National Health System, which aims to combine psychological and psychiatric services to treat the medically ill child, and is a Professor of Psychiatry and Pediatrics at the George Washington University.

Dr. Robb, who trained at Johns Hopkins University and the National Institutes of Health, has been on the medical staff in the Division of Psychiatry and Behavioral Medicine since 1996, rising to the rank of Professor (with tenure). She is an internationally known clinical researcher and directs a large clinical trial program in pediatric psychopharmacology for new agents being tested for FDA approval in children and teens.
X

Save 15% + Free Shipping on Online Orders!

Guilford Press

Save 15%:

Free Shipping:


For bulk orders, please contact: info@guilford.com
X